News

The Veeva CRM suite of applications includes VBioPharma, VMobile and VInsights. VBioPharma offers multiple editions in one CRM product to accommodate the unique needs of various life sciences

The pre-development agreement provides MorphoSys with an option to enter into a formal co-development for the respective program with Novartis. MorphoSys and Novartis entered into a strategic collaboration

The FAST dressing contains large quantities of the human blood clotting proteins fibrinogen, thrombin and Factor XIII in a dry form, which get instantly activated to form a

The collaboration is focused on translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation. The collaboration will support a number of activities over the

Under the agreement, Pfizer will have exclusive rights to commercialise these products globally, with certain exceptions, including co-exclusive rights for all of the products with Biocon in Germany,

Baraclude is indicated for the treatment of CHB infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or

Qutenza, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the US and the European Union. Qutenza is currently indicated in the

The product is expected to be manufactured under cGMP conditions as a kit for radio-labeling for use in clinical trials. Goodwin operations senior vice president SooYoung Lee said

MHRA has concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed. Almac Quality vice president Paul O’Connor